SCHEMBL14645264

SCHEMBL14645264

COC(=O)OB(O)c1cccs1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.36
KMT2A Q03164 5/20 0.36
GAA P10253 2/20 0.36
MEN1 O00255 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TP53 P04637 1/20 0.36
HDAC1 Q13547 1/20 0.35
TSHR P16473 3/20 0.35
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
APLNR P35414 1/20 0.35
LMNA P02545 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3665973 0.77
SCHEMBL8555010 0.73 SMN1; SMN2 (0.33) HPGDKMT2AGAAMEN1HSD17B10
SCHEMBL1237453 0.71 KMT2A (0.42) HPGDKMT2AHSD17B10RAB9ASMN1; SMN2
SCHEMBL5951665 0.69 DPP4 (0.39) HPGDKMT2AGAAMEN1HSD17B10
Hydrochloric Acid SCHEMBL3987325 0.69 KMT2A (0.41) HPGDKMT2AHSD17B10RAB9ASMN1; SMN2
SCHEMBL5050109 0.69 SMN1; SMN2 (0.32) GAAHSD17B10RAB9ANPC1SMN1; SMN2
SCHEMBL6220620 0.67 MMP1 (0.46) HPGDKMT2AGAAMEN1HSD17B10
SCHEMBL28354380 0.67 MMP1 (0.33) CES2CES1
SCHEMBL1186594 0.66
SCHEMBL526171 0.66 CES2 (0.39) KMT2AMEN1HSD17B10RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817304-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BioChromix NewCo AB (SE) 2014-12-31 EP disclosed
WO-2013009259-A1 NOVEL COMPOUNDS AND THEIR USE IN THERAPY BIOCHROMIX PHARMA AB (SE) 2013-01-17 WO disclosed